Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-11

Clinical Trial Update: Sublingual vs IV Atropine Bioavailability Study [Phase 1]

View source ↗

Summary

Phase 1 trial comparing sublingual to intravenous atropine bioavailability completed for toxic effects of organophosphate and carbamate insecticides.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine (atropine)

Snippet

Sponsor: Biomedical Advanced Research and Development Authority | Conditions: Toxic Effect of Organophosphate and Carbamate Insecticides | Phase 1 | Status: COMPLETED | Results posted: 2021-08-11